Categories: aggregated

New Study of Ketamine for Depression Disorders Gets FDA Approval, But Not Medical Marijuana

This is why the recent approval given by the FDA for a study on the use of ketamine infusion for depressive disorder has caught the eyes of many. It comes after a series of advocates have reportedly called for an increase in the available clinical data on the efficacy of ketamine for such conditions.

Jason

Share
Published by
Jason

Recent Posts

The Drink in Your Hand Was Never Just a Drink

The new cannabis beverage boom isn’t really about replacing booze. It’s about replacing everything people…

24 hours ago

Cannabis Equity Was Built to Repair the War on Drugs. Its Architect Says It Funneled Black Founders Into a Trap.

Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity…

24 hours ago

People are Dying While We Argue About a Plant Having Medicinal Properties

The finding: states that legalized medical or recreational marijuana saw significant reductions in non-fatal opioid…

24 hours ago

88% and Rising: America Has Already Made Up Its Mind on Cannabis Legalization

Eighty-eight percent. Let that sit for a moment. According to the latest nationwide polling from…

24 hours ago

He Won A Jet On MrBeast. Now He’s Linked To A 577-Pound Marijuana Trafficking Case.

A story that once sounded like peak internet fantasy has taken a very real turn. …

2 days ago

Star signs and cannabis strains: June 2026 horoscopes

Your June 2026 horoscopes brings a powerful mix of growth, reflection, and fresh opportunities. The…

2 days ago